ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.31X leverage
AstraZeneca Pharma India live price: ₹8849. It opened at ₹8,800 vs previous close ₹8,668; intraday high/low: ₹8,849/₹8,615. The 50 & 200 DMA stand at ₹8,757.44/₹8,671.26.
AstraZeneca Pharma India Performance
- Low
- ₹8,615
- High
- ₹8,849
- 52 Week Low
- ₹7,201
- 52 Week High
- ₹10,691
- Open Price₹8,800
- Previous Close₹8,668
- Volume2,064
- 50 DMA₹8,757.44
- 100 DMA₹8,803.78
- 200 DMA₹8,671.26
Investment Returns
- Over 1 Month + 2.02%
- Over 3 Month -2.04%
- Over 6 Month -2.76%
- Over 1 Year + 18.49%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 110.1
- PEG Ratio
- 1
- Market Cap Cr
- 22,123
- P/B Ratio
- 26.6
- Average True Range
- 212.97
- EPS
- 83.21
- Dividend Yield
- 0.4
- MACD Signal
- 37.67
- RSI
- 45.23
- MFI
- 28.63
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,849.00
+
181.5
(2.09%)
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹8,756.43
- 50 Day
- ₹8,757.44
- 100 Day
- ₹8,803.78
- 200 Day
- ₹8,671.26
Resistance and Support
8614
- R3 8,979.00
- R2 8,839.50
- R1 8,753.50
- S1 8,528.00
- S2 8,388.50
- S3 8,302.50
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,849 As on 10 March, 2026 | 12:57
The Market Cap of AstraZeneca Pharma India is ₹22122.5 Cr As on 10 March, 2026 | 12:57
The P/E ratio of AstraZeneca Pharma India is 110.1 As on 10 March, 2026 | 12:57
The PB ratio of AstraZeneca Pharma India is 26.6 As on 10 March, 2026 | 12:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.